Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lin

Showing results (741-750 of 792) with videos related to

Pageof 80
Sort By:
British Journal of Cancer|June 4, 2014
Dichloroacetate induces autophagy in colorectal cancer cells and tumoursG Lin, D K Hill, G Andrejeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Surgical stress promotes tumor growth in ovarian carcinomaJeong-Won Lee, Mian M K Shahzad, Yvonne G Lin, et al.
Cancer Biology & Therapy|October 16, 2010
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerWilliam M Merritt, Aparna A Kamat, Jee-Young Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Cancer Research|February 12, 2020
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy ResistanceAnkush Chandra, Arman Jahangiri, William Chen, et al.
Breast (Edinburgh, Scotland)|June 22, 2026
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancerL Gianni, S Delaloge, E Ciruelos, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical TrialCharles N Landen, Luciana Molinero, Habib Hamidi, et al.
Cancer Discovery|December 20, 2011
A novel platform for detection of CK+ and CK- CTCsChad V Pecot, Farideh Z Bischoff, Julie Ann Mayer, et al.
Molecular Cancer Therapeutics|August 5, 2010
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinomaWhitney A Spannuth, Lingegowda S Mangala, Rebecca L Stone, et al.
Pageof 80

Showing results (741-750 of 792) with videos related to

Sort By:
Pageof 80
British Journal of Cancer|June 4, 2014
Dichloroacetate induces autophagy in colorectal cancer cells and tumoursG Lin, D K Hill, G Andrejeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Surgical stress promotes tumor growth in ovarian carcinomaJeong-Won Lee, Mian M K Shahzad, Yvonne G Lin, et al.
Cancer Biology & Therapy|October 16, 2010
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancerWilliam M Merritt, Aparna A Kamat, Jee-Young Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Cancer Research|February 12, 2020
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy ResistanceAnkush Chandra, Arman Jahangiri, William Chen, et al.
Breast (Edinburgh, Scotland)|June 22, 2026
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancerL Gianni, S Delaloge, E Ciruelos, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical TrialCharles N Landen, Luciana Molinero, Habib Hamidi, et al.
Cancer Discovery|December 20, 2011
A novel platform for detection of CK+ and CK- CTCsChad V Pecot, Farideh Z Bischoff, Julie Ann Mayer, et al.
Molecular Cancer Therapeutics|August 5, 2010
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinomaWhitney A Spannuth, Lingegowda S Mangala, Rebecca L Stone, et al.
Pageof 80